4 results
To evaluate the long-term safety and tolerability of ralinepag (ADP811) in subjects who participated in a preceding Phase 2 or Phase 3 study of ralinepag.
Primary ObjectivesThe primary objectives for this study are as follows:* To evaluate the safety and tolerability of atezolizumab and ipilimumab when administered in combination in patients with advanced or metastatic non-small cell lung cancer (…
To demonstrate the effect of ralinepag on the time to first adjudicated protocol-defined clinical worsening event in subjects with PAH.
The purpose of this study is to demonstrate the efficacy of 9-valentextraintestinal pathogenic Escherichia coli vaccine (ExPEC9V) compared toplacebo in the prevention of the first invasive extraintestinal pathogenicEscherichia coli disease (IED)…